Brokerages Set The Chemours Company (NYSE:CC) PT at $17.00

Shares of The Chemours Company (NYSE:CC) have received an average rating of “Hold” from the eleven research firms that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $17.00.

A number of research firms recently issued reports on CC. UBS Group dropped their price objective on shares of Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a report on Tuesday, November 11th. Mizuho dropped their price target on shares of Chemours from $19.00 to $18.00 and set an “outperform” rating on the stock in a research note on Thursday, October 16th. Weiss Ratings reissued a “sell (d)” rating on shares of Chemours in a research report on Wednesday, October 8th. Truist Financial decreased their target price on Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a report on Monday, November 10th. Finally, Zacks Research downgraded Chemours from a “hold” rating to a “strong sell” rating in a research report on Friday, October 17th.

Chemours Stock Performance

CC stock opened at $14.31 on Thursday. The company has a debt-to-equity ratio of 13.66, a current ratio of 1.71 and a quick ratio of 0.88. Chemours has a 1 year low of $9.13 and a 1 year high of $20.12. The company has a market cap of $2.14 billion, a P/E ratio of -6.44 and a beta of 1.61. The stock’s fifty day moving average price is $12.25 and its 200-day moving average price is $13.57.

Chemours (NYSE:CC) last posted its earnings results on Thursday, November 6th. The specialty chemicals company reported $0.20 earnings per share for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.04). The firm had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.50 billion. Chemours had a negative net margin of 5.70% and a positive return on equity of 35.27%. The firm’s revenue was down .9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.40 EPS. On average, equities analysts forecast that Chemours will post 2.03 earnings per share for the current year.

Chemours Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were given a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Friday, November 14th. Chemours’s payout ratio is presently -15.77%.

Institutional Investors Weigh In On Chemours

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. MTM Investment Management LLC purchased a new stake in shares of Chemours in the second quarter worth $27,000. GAMMA Investing LLC boosted its holdings in Chemours by 130.7% in the 2nd quarter. GAMMA Investing LLC now owns 3,175 shares of the specialty chemicals company’s stock worth $36,000 after buying an additional 1,799 shares during the period. Evelyn Partners Asset Management Ltd purchased a new stake in Chemours in the 2nd quarter worth $37,000. Caitong International Asset Management Co. Ltd bought a new stake in Chemours during the third quarter valued at about $43,000. Finally, FNY Investment Advisers LLC raised its holdings in Chemours by 100.0% during the second quarter. FNY Investment Advisers LLC now owns 4,000 shares of the specialty chemicals company’s stock valued at $45,000 after acquiring an additional 2,000 shares during the period. Institutional investors own 76.26% of the company’s stock.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.